Telemedicine in Liver Disease and Beyond: Can the COVID‐19 Crisis Lead to Action?
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline‐recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis‐related complications result in inpatient specialty care, and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community‐based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, although it is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 has, in the short term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non‐crisis situations, using a case series from our telehepatology program as a pragmatic example.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APASL Covid-19 Task Force, Lau, G., & Sharma, M. (2020) · Hepatology International · doi:10.1007/s12072-020-10054-w · Cited by 88
Cited by
Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic
Jnr., B. A. (2020) · Journal of Medical Systems · doi:10.1007/s10916-020-01596-5 · Cited by 800
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Golinelli, D., Boetto, E., Carullo, G., Nuzzolese, A. G., Landini, M. P., & Fantini, M. P. (2020) · Journal of Medical Internet Research · doi:10.2196/22280 · Cited by 574
Challenges of Telemedicine during the COVID-19 pandemic: a systematic review
Ftouni, R., AlJardali, B., Hamdanieh, M., Ftouni, L., & Salem, N. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01952-0 · Cited by 291
COVID-19 and healthcare system in China: challenges and progression for a sustainable future
Sun, S., Xie, Z., Yu, K., Jiang, B., Zheng, S., & Pan, X. (2021) · Globalization and Health · doi:10.1186/s12992-021-00665-9 · Cited by 191
Metadata
- Authors
- Serper, M., Cubell, A. W., Deleener, M. E., Casher, T. K., Rosenberg, D. J., Whitebloom, D., & Rosin, R. M.
- Venue
- Hepatology
- Published
- 2020-08
- Volume
- 72
- Issue
- 2
- Pages
- 723-728
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3015421112
- Cited by
- 138
- References
- 1
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telemedicine in Liver Disease and Beyond: Can the COVID‐19 Crisis Lead to Action? https://app.cochat.ai/papers/10.1002/hep.31276
- The paper
- Serper, M., Cubell, A. W., Deleener, M. E., Casher, T. K., Rosenberg, D. J., Whitebloom, D., & Rosin, R. M. (2020). Telemedicine in Liver Disease and Beyond: Can the COVID‐19 Crisis Lead to Action? Hepatology. https://doi.org/10.1002/hep.31276
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.